enGene Holdings Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | |
| – | – | -2.5% | +5.1% | – | – | +3.9% | +22.6% | +31.5% | +10.5% | -4.8% | -1.1% | – | |
| – | – | – | – | – | -142.5% | – | – | – | – | – | – | – | |
| – | -0.6% | +74.8% | +17.2% | -2.4% | +77.2% | +1.2% | +11.7% | +40.5% | -29.8% | -0.3% | -9.5% | – | |
| – | -18.0% | +67.5% | -23.1% | +64.5% | -13.8% | -9.9% | +11.7% | +50.1% | -10.9% | +9.4% | +42.5% | – | |
| – | +3.2% | +60.7% | -3.2% | +4.2% | +52.5% | +1.9% | +10.4% | +31.8% | -21.5% | +3.1% | +6.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | +6.4% | – | |
| – | -51.4% | +29.3% | +3.2% | +0.7% | -0.5% | -2.4% | +3.3% | -1.1% | -2.4% | +1.8% | +13.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | +7.5% | – | |
| – | – | – | -238.1% | – | -5.3% | +1,233.3% | -0.4% | -307.9% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +7.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.